The global Biopharmaceutical
CMO and CRO Market size is estimated to generate revenues of more than USD 59.13 billion by 2030, growing at a CAGR of around 7.4% from
2022 to 2030
The report covers SWOT analysis, market valuation, competitive spectrum,
regional share, and revenue predictions. The report offers an analysis of the global biopharmaceutical
CMO and CRO Market for the period 2017 to 2030, wherein 2022 to 2030 is the
forecast period and 2021 is considered as the base year.
The wide application portfolio of biopharmaceutical CMO and CRO market
is one of factors driving the growth of market worldwide. The global market is
moderately competitive with a blend of global and regional players. The markets
key players invest significantly in R and D to enhance their offerings. The
entire ecosystem is composed of multiple participants. Every participant of the
ecosystem is an equal contributor to the growth of global market.
Why should
you invest in this report?
If you are aiming to enter the global biopharmaceutical
CMO and CRO Market, this report is a comprehensive guide that provides crystal
clear insights into this niche market. All the major application areas for biopharmaceutical
CMO and CRO are covered in this report and information is given on the
important regions of the world where this market is likely to boom during the
forecast period of 2022-2030, so that you can plan your strategies to enter
this market accordingly. Besides, through this report, you can have a complete
grasp of the level of competition you will be facing in this hugely competitive
market and if you are an established player in this market already, this report
will help you gauge the strategies that your competitors have adopted to stay
as market leaders in this market. For new entrants to this market, the
voluminous data provided in this report is invaluable.
Report Scope of the Biopharmaceutical CMO and CRO Market
| Report Highlights | Details |
| Market Size | USD 59.4 Billion by 2030 |
| Growth Rate | CAGR of 7.4% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, Source, Service |
| Regional Scope | North America, APAC, Europe, Latin America, MEAN, Rest of the World |
| Companies Mentioned | Samsung Biologics, Lonza, BoehringerIngelheim, Patheon, CMC Biologics, TOYOBO Co. Ltd., JRS Pharma, RentschlerBiotechnologie, FUJIFILM Diosynth Biotechnologies, WuXi Biologics, PRA Health Sciences, LabCorp |
Report Structure:
- pertinent
market numbers of the global biopharmaceutical CMO and CRO market along
with the CAGR for the forecast period 2022-2030
- detailed
definitions of different types of biopharmaceutical CMO and CRO, which
gives clarity about what this market is all about and also defines the
scope of this report
- macroeconomic
factors influencing the global biopharmaceutical CMO and CRO market, along
with market opportunity analysis
- key
trends likely to impact the global biopharmaceutical CMO and CRO market
- PESTLE
analysis of all the regions as per the market taxonomy
- Porter’s
Five Force Analysis of all the regions as given in the market taxonomy
Global market analysis and forecast:
- the
global biopharmaceutical CMO and CRO market analysis and forecast by
product type, by application, by region and others
- key
market metrics such as the BPS analysis, year-on-year growth rates,
absolute dollar opportunity and market attractiveness analysis of the
global biopharmaceutical CMO and CRO market
Regional market analysis and forecast:
- Regional
biopharmaceutical CMO and CRO market analysis and forecast
- Regional
market dynamics including the drivers, restraints and trends applicable
across different regions in the biopharmaceutical CMO and CRO market along
with factors encouraging the growth of this market as well as the factors
hampering the growth of this market
- Regional
trends – both long term and short term
View Full Report@
https://www.precedenceresearch.com/biopharmaceutical-cmo-and-cro-market
Competitive landscape:
- the
competitive landscape of this global report
- information
on the various leading companies in the global market
- a
dashboard view of the key companies operating in the global market along
with their important information and broad strategy adopted to stay as
leaders in the global market
- key
company profiles along with important information such as company details,
company description, product portfolio along with key developments concerning
the company and strategic analysis
Some of the prominent players in biopharmaceutical
CMO and CRO market include:
- Lonza
- JRS Pharma
- Samsung Biologics
- CMC Biologics
- TOYOBO Co. Ltd.
- RentschlerBiotechnologie
- FUJIFILM Diosynth
Biotechnologies
- WuXi Biologics
- Patheon
- BoehringerIngelheim
- PRA Health Sciences
- LabCorp
Market Segmentation:
By Service
- Contract Manufacturing
- Process Development
- Upstream
- Downstream
- Fill & Finish
Operations
- Analytical & QC
studies
- Packaging
- Contract Research
- Inflammation &
Immunology
- Cardiology
- Oncology
- Neuroscience
- Others
By Source
- Mammalian
- Non-Mammalian
By Product
- Biologics
- Vaccines
- Monoclonal antibodies
(MABs)
- Recombinant Proteins
- Antisense, RNAi,
& Molecular Therapy
- Others
- Biosimilars
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Research Methodology
In this report, historical data, primary
responses and public domain data has been thoroughly analyzed to infer the
market size. Revenue of companies operating in the global market has been
benchmarked to ascertain the market size for the base year. Macroeconomic
indicators such as GDP and industry growth have been considered to determine
the market size for the forecast period. The historical growth trend of end-use
industries, market participants’ performance, as well as the present
macro-economic outlook has been taken into consideration for estimating the
overall market trend forecast. This data is then validated using the
triangulation method and extensively scrutinized using advanced tools to garner
quantitative and qualitative insights into the global biopharmaceutical CMO and
CRO.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research
Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions &
Limitations
Chapter 3. Executive
Summary
3.1. Market Snapshot
Chapter 4. Market Variables
and Scope
4.1. Introduction
4.2. Market Classification
and Scope
4.3. Industry Value Chain
Analysis
4.3.1. Raw Material
Procurement Analysis
4.3.2. Sales and Source
Analysis
4.3.3. Downstream Buyer
Analysis
Chapter 5. Market Dynamics
Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces
Analysis
5.2.1. Bargaining power of
suppliers
5.2.2. Bargaining power of
buyers
5.2.3. Threat of substitute
5.2.4. Threat of new
entrants
5.2.5. Degree of
competition
Chapter 6. Competitive
Landscape
6.1.1. Company Market
Share/Positioning Analysis
6.1.2. Key Strategies
Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global
Biopharmaceutical CMO and CRO Market, By Product
7.1. Biopharmaceutical CMO
and CRO Market, by Product Type, 2021-2030
7.1.1. Biologics (Vaccines,
Monoclonal antibodies (MABs), Recombinant Proteins, Others)
7.1.1.1. Market Revenue and
Forecast (2019-2030)
7.1.2. Biosimilars
7.1.2.1. Market Revenue and
Forecast (2019-2030)
Chapter 8. Global
Biopharmaceutical CMO and CRO Market, By Service
8.1. Biopharmaceutical CMO
and CRO Market, by Service, 2021-2030
8.1.1. Contract
Manufacturing (Process Development, Fill & Finish Operations, Analytical
& QC studies, Packaging)
8.1.1.1. Market Revenue and
Forecast (2019-2030)
8.1.2. Contract Research
(Inflammation & Immunology, Cardiology, Oncology, Neuroscience, Others)
8.1.2.1. Market Revenue and
Forecast (2019-2030)
Chapter 9. Global
Biopharmaceutical CMO and CRO Market, By Source
9.1. Biopharmaceutical CMO
and CRO Market, by Source, 2021-2030
9.1.1. Mammalian
9.1.1.1. Market Revenue and
Forecast (2019-2030)
9.1.2. Non-Mammalian
9.1.2.1. Market Revenue and
Forecast (2019-2030)
Chapter 10. Global
Biopharmaceutical CMO and CRO Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and
Forecast, by Product (2019-2030)
10.1.2. Market Revenue and
Forecast, by Service (2019-2030)
10.1.3. Market Revenue and
Forecast, by Source (2019-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue
and Forecast, by Product (2019-2030)
10.1.4.2. Market Revenue
and Forecast, by Service (2019-2030)
10.1.4.3. Market Revenue
and Forecast, by Source (2019-2030)
10.1.5. Rest of North
America
10.1.5.1. Market Revenue
and Forecast, by Product (2019-2030)
10.1.5.2. Market Revenue
and Forecast, by Service (2019-2030)
10.1.5.3. Market Revenue
and Forecast, by Source (2019-2030)
10.2. Europe
10.2.1. Market Revenue and
Forecast, by Product (2019-2030)
10.2.2. Market Revenue and
Forecast, by Service (2019-2030)
10.2.3. Market Revenue and
Forecast, by Source (2019-2030)
10.2.4. UK
10.2.4.1. Market Revenue
and Forecast, by Product (2019-2030)
10.2.4.2. Market Revenue
and Forecast, by Service (2019-2030)
10.2.4.3. Market Revenue
and Forecast, by Source (2019-2030)
10.2.5. Germany
10.2.5.1. Market Revenue
and Forecast, by Product (2019-2030)
10.2.5.2. Market Revenue
and Forecast, by Service (2019-2030)
10.2.5.3. Market Revenue
and Forecast, by Source (2019-2030)
10.2.6. France
10.2.6.1. Market Revenue
and Forecast, by Product (2019-2030)
10.2.6.2. Market Revenue
and Forecast, by Service (2019-2030)
10.2.6.3. Market Revenue
and Forecast, by Source (2019-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue
and Forecast, by Product (2019-2030)
10.2.7.2. Market Revenue
and Forecast, by Service (2019-2030)
10.2.7.3. Market Revenue
and Forecast, by Source (2019-2030)
10.3. APAC
10.3.1. Market Revenue and
Forecast, by Product (2019-2030)
10.3.2. Market Revenue and
Forecast, by Service (2019-2030)
10.3.3. Market Revenue and
Forecast, by Source (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue
and Forecast, by Product (2019-2030)
10.3.4.2. Market Revenue
and Forecast, by Service (2019-2030)
10.3.4.3. Market Revenue
and Forecast, by Source (2019-2030)
10.3.5. China
10.3.5.1. Market Revenue
and Forecast, by Product (2019-2030)
10.3.5.2. Market Revenue
and Forecast, by Service (2019-2030)
10.3.5.3. Market Revenue
and Forecast, by Source (2019-2030)
10.3.6. Japan
10.3.6.1. Market Revenue
and Forecast, by Product (2019-2030)
10.3.6.2. Market Revenue
and Forecast, by Service (2019-2030)
10.3.6.3. Market Revenue
and Forecast, by Source (2019-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue
and Forecast, by Product (2019-2030)
10.3.7.2. Market Revenue
and Forecast, by Service (2019-2030)
10.3.7.3. Market Revenue
and Forecast, by Source (2019-2030)
10.4. MEA
10.4.1. Market Revenue and
Forecast, by Product (2019-2030)
10.4.2. Market Revenue and
Forecast, by Service (2019-2030)
10.4.3. Market Revenue and
Forecast, by Source (2019-2030)
10.4.4. GCC
10.4.4.1. Market Revenue
and Forecast, by Product (2019-2030)
10.4.4.2. Market Revenue
and Forecast, by Service (2019-2030)
10.4.4.3. Market Revenue
and Forecast, by Source (2019-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue
and Forecast, by Product (2019-2030)
10.4.5.2. Market Revenue
and Forecast, by Service (2019-2030)
10.4.5.3. Market Revenue
and Forecast, by Source (2019-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue
and Forecast, by Product (2019-2030)
10.4.6.2. Market Revenue
and Forecast, by Service (2019-2030)
10.4.6.3. Market Revenue
and Forecast, by Source (2019-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue
and Forecast, by Product (2019-2030)
10.4.7.2. Market Revenue
and Forecast, by Service (2019-2030)
10.4.7.3. Market Revenue
and Forecast, by Source (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and
Forecast, by Product (2019-2030)
10.5.2. Market Revenue and
Forecast, by Service (2019-2030)
10.5.3. Market Revenue and
Forecast, by Source (2019-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue
and Forecast, by Product (2019-2030)
10.5.4.2. Market Revenue
and Forecast, by Service (2019-2030)
10.5.4.3. Market Revenue
and Forecast, by Source (2019-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue
and Forecast, by Product (2019-2030)
10.5.5.2. Market Revenue
and Forecast, by Service (2019-2030)
10.5.5.3. Market Revenue
and Forecast, by Source (2019-2030)
Chapter 11. Company
Profiles
11.1. Lonza
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial
Performance
11.1.4. Recent Initiatives
11.2. JRS Pharma
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Samsung Biologics
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial
Performance
11.3.4. Recent Initiatives
11.4. CMC Biologics
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. TOYOBO Co. Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial
Performance
11.5.4. Recent Initiatives
11.6.
RentschlerBiotechnologie
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial
Performance
11.6.4. Recent Initiatives
11.7. FUJIFILM Diosynth
Biotechnologies
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial
Performance
11.7.4. Recent Initiatives
11.8. WuXi Biologics
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial
Performance
11.8.4. Recent Initiatives
11.9. Patheon
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial
Performance
11.9.4. Recent Initiatives
11.10. BoehringerIngelheim
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial
Performance
11.10.4. Recent Initiatives
11.11. PRA Health Sciences
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial
Performance
11.11.4. Recent Initiatives
11.12. LabCorp
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial
Performance
11.12.4. Recent Initiatives
Chapter 12. Research
Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 comments:
Post a Comment